Anthem (NASDAQ:ANTX) Director Margaret Fitzpatrick Purchases 2,098 Shares

Anthem, Inc. (NASDAQ:ANTX) Director Margaret Fitzpatrick bought 2,098 shares of the stock in a transaction dated Tuesday, September 1st. The shares were purchased at an average cost of $5.53 per share, for a total transaction of $11,601.94. Following the completion of the purchase, the director owned 10,708 shares in the company, valued at approximately $59,215.24. This represents a 24.37% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Anthem Stock Up 8.6%

NASDAQ:ANTX opened at $5.95 on Thursday. Anthem, Inc. has a 52 week low of $1.00 and a 52 week high of $7.19. The stock’s 50-day moving average price is $5.26 and its 200-day moving average price is $4.27. The stock has a market capitalization of $224.55 million, a PE ratio of -5.56 and a beta of -0.99.

Anthem (NASDAQ:ANTX) last released its quarterly earnings results on Tuesday, August 11th. The company reported ($0.18) earnings per share for the quarter.

Institutional Trading of Anthem

Institutional investors and hedge funds have recently bought and sold shares of the stock. Spruce Street Capital LP purchased a new position in Anthem during the first quarter worth about $5,576,000. OMERS ADMINISTRATION Corp acquired a new position in shares of Anthem in the 1st quarter worth approximately $54,000. Commodore Capital LP acquired a new position in shares of Anthem in the 1st quarter worth approximately $7,981,000. ADAR1 Capital Management LLC purchased a new position in shares of Anthem during the 1st quarter worth approximately $47,000. Finally, Ally Bridge Group NY LLC purchased a new position in shares of Anthem during the 1st quarter worth approximately $1,800,000. 90.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have commented on the stock. Wall Street Zen upgraded shares of Anthem from a “sell” rating to a “hold” rating in a report on Sunday, June 14th. Weiss Ratings restated a “sell (d-)” rating on shares of Anthem in a report on Monday, July 6th. Leerink Partners upgraded Anthem from a “market perform” rating to an “outperform” rating and set a $9.00 price target for the company in a research report on Thursday, May 14th. Finally, Guggenheim initiated coverage on Anthem in a research report on Monday, July 20th. They set a “buy” rating and a $9.00 price objective on the stock. Two research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $9.00.

About Anthem

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through three segments: Commercial & Specialty Business, Government Business, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small group, individual, Medicaid, and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; traditional indemnity plans and other hybrid plans, such as consumer-driven health plans; and hospital only and limited benefit products.